- Release Date: 09/03/09 10:27
- Summary: Norwood Immunology Sale of Virosome
- Price Sensitive: No
- Download Document 403.73KB
- Forums
- ASX - By Stock
- NAL
- Ann: Norwood Immunology Sale of Virosome
Ann: Norwood Immunology Sale of Virosome
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
NEWS
Breakthrough programs slash healthcare events, driving a significant A$1.8M+ annual revenue boost